Focus Partners Advisor Solutions LLC Has $1.32 Million Stock Position in Humana Inc. $HUM

Key Points

• Focus Partners Advisor Solutions LLC increased its stake in Humana Inc. by 226.9%, acquiring an additional 3,455 shares to bring its total holdings to 4,978 shares valued at approximately $1.32 million.
• Humana's recent quarterly earnings reported an EPS of $6.27, missing estimates by $0.05, while revenues increased by 9.6% year-over-year.
• The company's stock has a current market capitalization of $37.29 billion and a consensus rating of "Hold" from analysts, with a target price averaging $285.76.

Focus Partners Advisor Solutions LLC raised its position in Humana Inc. (NYSE:HUM - Free Report) by 226.9% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 4,978 shares of the insurance provider's stock after buying an additional 3,455 shares during the period. Focus Partners Advisor Solutions LLC's holdings in Humana were worth $1,317,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of HUM. Cary Street Partners Investment Advisory LLC increased its position in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after acquiring an additional 46 shares during the last quarter. Applied Finance Capital Management LLC increased its position in Humana by 1.7% during the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock worth $779,000 after buying an additional 48 shares during the last quarter. Achmea Investment Management B.V. increased its position in Humana by 0.5% during the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after buying an additional 49 shares during the last quarter. Beech Hill Advisors Inc. increased its position in Humana by 6.1% during the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock worth $229,000 after buying an additional 50 shares during the last quarter. Finally, Townsquare Capital LLC increased its position in Humana by 2.8% during the first quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider's stock worth $597,000 after buying an additional 61 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Performance

Shares of NYSE:HUM traded down $4.07 during trading on Friday, reaching $307.94. 1,504,536 shares of the stock were exchanged, compared to its average volume of 1,364,503. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm has a market cap of $37.04 billion, a PE ratio of 23.63, a PEG ratio of 1.83 and a beta of 0.44. The stock has a 50-day moving average price of $261.46 and a 200-day moving average price of $256.47. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $369.17.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The company's quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Friday, September 26th. Humana's payout ratio is 27.17%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on HUM shares. Piper Sandler lowered their price target on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research report on Thursday, July 31st. Sanford C. Bernstein boosted their price target on Humana from $269.00 to $341.00 and gave the stock an "outperform" rating in a research report on Friday. Bank of America boosted their price target on Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a research report on Tuesday. Barclays boosted their price target on Humana from $275.00 to $315.00 and gave the stock an "equal weight" rating in a research report on Friday. Finally, Wall Street Zen cut Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Seven analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $289.24.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.